South Africa faces criticism for reselling vaccines against AstraZeneca

Health law and business

March 25, 2021, 3:52 p.m.

Six leading medical scientists in South Africa say the government’s decision to sell a million coronavirus vaccines has developed AstraZeneca Plc it is questionable to other African countries because it has not established their effectiveness against the variant that is widespread on the continent.

South Africa bought the footage from Serum Institute from India Ltd., which produces the vaccine under license. He suspended their introduction to health workers in February, after a small study showed that they were mostly ineffective in stopping a mild disease caused by a viral variant that was first identified in South Africa late last year. The …

Source